
|Articles|June 4, 2007
Latebreakers: OC approved for continuous use
A new birth control pill that is taken daily 365 days a year has received approval. The FDA gave Wyeth the go-ahead for Lybrel, a combination oral contraceptive (OC) that contains 90 mcg levonorgestrel and 20 mcg ethinyl estradiol.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Plant-Based Diet Shows Potential in Active Diabetes Remission
2
How New Federal Spending Bill Bolsters CMS Oversight, PBM Transparency
3
How Pharmacists Reshape Health Care Access and Drive the Future of Patient Care
4
Pharmacy Law Lowdown: Legislative Shifts in 2026 PBM Reform
5






















